Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine added to standard home treatment for heart failure exacerbation
NL-OMON35847Phase 3Recruiting
- Sponsor
- Isala
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dopamine in heart failure (HF) (2 arms), sponsored by Isala. Primary endpoint: Unplanned hospital admission for heart failure. Started Nov 2011; status: recruiting.
02
Drugs
dopamine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NL-OMON35847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35847.